Sentimag® Platform
The all-in-one breast surgery platform to mark and localise lesions and lymph nodes. No wires. No radioactivity.
Overview
Documents
Localisation and Staging Together in One Platform
The unique magnetic technology of the Sentimag system, alongside the Magseed® markers and Magtrace® lymphatic tracer, provides you with a proven, accurate and flexible approach to surgery.1
Simple
Mark. Detect. Remove. The Sentimag platform makes tissue localisation straightforward.
Intuitive
Easy-to-use probes with intuitive audio feedback and unique visual identification.
Precise
Our technologies are designed to guide you to the location of your target.
Versatile
One platform enables multiple techniques, from lesion localisation and sentinel lymph node biopsy to targeted axillary dissection and delayed SLNB.
Unlock the Advantage of Time
The Breast Health Continuum of Care offers integrated solutions for clinical confidence, workflow efficiency and compassionate patient care. It gives more women, more time in better health.
The Sentimag Platform is part of the Hologic Breast Surgery Solution.
Clinical Evidence
Simple to adopt and supported by extensive clinical evidence, the Sentimag platform is trusted by thousands of clinicians worldwide to deliver effective, patient-centered breast cancer care.
25,000+
patients involved in clinical studies from around the world.2
750,000+
patients now treated with the Sentimag® platform.3
1,350+
hospitals treating patients with the Sentimag platform, across 45 countries.
Slimmer Probe for Smaller Incisions
The new thinner Sentimag probe features an ergonomic profile with a soft-grip finish for improved handling. Its slim design supports precise localisation through smaller incisions, offering easier access and greater visibility in oncoplastic cases.
Visit Our Virtual Hospital
Browse our portfolio of Breast Health solutions in 3D. See how you can unlock the advantage of time across the entire Breast Continuum of Care.
Insights
Data on file at Endomag. Scientific and Clinical Literature Review – Magtrace – November 2025 (P415J003). Data correct as of March 2026.
Data on file at Endomag. Internal Meta-Analysis 270525 of Clinical Studies. Data correct as of March 2026.
Sales data on file at Endomag. Data Correct as of March 2026.
2797
Emergo Europe BV, Westervoortsedijk 60, 6827 AT Arnhem, The Netherlands.
Notified Body number wherever applicable
EC Representative Information wherever applicable